Tejas V. Patel, MD, MPH, FACP, FASN
Patel TV. Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia. Ann Intern Med. 2010;152:JC3–9. doi: 10.7326/0003-4819-152-6-201003160-02009
Download citation file:
Published: Ann Intern Med. 2010;152(6):JC3-9.
Cardiology, Chronic Kidney Disease, Coronary Risk Factors, Diabetes, Diabetic Nephropathy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use